These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20044669)

  • 1. Naltrexone implants.
    Kelly KI; McBride A
    Br J Psychiatry; 2010 Jan; 196(1):77; author reply 77. PubMed ID: 20044669
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone implants as treatment for heroin dependence: part I.
    Byrne A; Graham G; Hallinan R; Murnion B
    Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of information in naltrexone study.
    Rastegar DA
    Arch Gen Psychiatry; 2007 Jul; 64(7):865; author reply 865. PubMed ID: 17606820
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of heroin-dependent persons with antagonists: current status.
    Renault PF
    Bull Narc; 1978; 30(2):21-9. PubMed ID: 252920
    [No Abstract]   [Full Text] [Related]  

  • 7. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    Hulse GK; O'Neil G; Arnold-Reed DE
    Int J Gynaecol Obstet; 2004 May; 85(2):170-1. PubMed ID: 15099783
    [No Abstract]   [Full Text] [Related]  

  • 8. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
    Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson RC
    Addict Biol; 2004 Mar; 9(1):67-72. PubMed ID: 15203441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.
    Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson R; O'Neil P
    Addict Biol; 2004 Mar; 9(1):59-65. PubMed ID: 15203440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
    Brewer C; Wong VS
    Addict Biol; 2004 Mar; 9(1):81-7. PubMed ID: 15203443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone implants as treatment for heroin dependence: part II.
    Wodak A; Graham R
    Addict Biol; 2005 Jun; 10(2):202; author reply 202-4. PubMed ID: 16201030
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of heroin-dependent persons with antagonists: current status.
    Renault PF
    NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Heilig M
    Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.
    Hulse GK; Ngo HT; Tait RJ
    Biol Psychiatry; 2010 Aug; 68(3):296-302. PubMed ID: 20537615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset mania and psychosis following heroin detoxification and naltrexone maintenance.
    Sullivan MA; Nunes EV
    Am J Addict; 2005; 14(5):486-7. PubMed ID: 16257886
    [No Abstract]   [Full Text] [Related]  

  • 19. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
    Presenza LJ
    J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.